Answer
The mean terminal elimination half-life of nusinersen sodium in cerebrospinal fluid in paediatric patients with spinal muscular atrophy is estimated at 135 to 177 days.
Sources for this answer
- Spinraza 12 mg solution for injectionBiogen Idec Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 17Document updated
Sources checked